Detected ·
Alamar Biosciences, Inc.
——
Alamar Biosciences has priced its IPO, becoming the first Diagnostics Accelerator-supported company to reach this stage, advancing ultra-sensitive blood-based biomarker detection for Alzheimer's diagnosis.
- Website
- www.alamarbio.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-04-22 00:07:12 UTC
- Signal ID
- a2811ad4-7733-4604-873f-ed83fa499fc3
As the API returns it
{
"id": "a2811ad4-7733-4604-873f-ed83fa499fc3",
"created_at": "2026-04-22T00:07:12.617903Z",
"company_name": "Alamar Biosciences, Inc.",
"company_website_url": "www.alamarbio.com",
"company_linkedin_url": "https://www.linkedin.com/company/alamar-biosciences-inc",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Alamar Biosciences has priced its IPO, becoming the first Diagnostics Accelerator-supported company to reach this stage, advancing ultra-sensitive blood-based biomarker detection for Alzheimer's diagnosis.*"
}